Ioanna D. Gemünd

1.4k citations
3 papers · 568 indexed · 1 hit paper · h-index 3
Topics
SARS-CoV-2 and COVID-19 Research (1 paper)Immune responses and vaccinations (1 paper)COVID-19 Clinical Research Studies (1 paper)
Partner nations
GermanyAustraliaItaly

In The Last Decade

Ioanna D. Gemünd

3 papers receiving 565 citations

Hit Papers

Human Monocyte Subsets and Phenotypes in Major Chronic In...20192026202120232019100200300400500

Peers

Ioanna D. Gemünd
Comparison fields: 5 of 86
  • Immunology 311
  • Molecular Biology 137
  • Oncology 75
  • Epidemiology 74
  • Infectious Diseases 66
Replace Emily Hinkley with:
Emily Hinkley Germany
Adem Saglam Germany
Emily M. L. Chastain United States
Andreas Lossius Norway
Nico Reusch Germany
Lauren A. Callender United Kingdom
Lorenzo Bonaguro Germany
Pravat Kumar Thatoi India
Pasquine Saule France
Rémy Boscacci Switzerland
Ioanna D. Gemünd relative to Emily Hinkley Germany Emily Hinkley's profile →
Citations per field
00.5×1.5×
Emily Hinkley · 1×
Citations per year

Countries citing papers authored by Ioanna D. Gemünd

Since Specialization
Citations

This map shows the geographic impact of Ioanna D. Gemünd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ioanna D. Gemünd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ioanna D. Gemünd more than expected).

Fields of papers citing papers by Ioanna D. Gemünd

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ioanna D. Gemünd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ioanna D. Gemünd. The network helps show where Ioanna D. Gemünd may publish in the future.

Co-authorship network of co-authors of Ioanna D. Gemünd

This figure shows the co-authorship network connecting the top 25 collaborators of Ioanna D. Gemünd. A scholar is included among the top collaborators of Ioanna D. Gemünd based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ioanna D. Gemünd. Ioanna D. Gemünd is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

About Ioanna D. Gemünd

Ioanna D. Gemünd is a scholar working on Neurology, Neurology and Infectious Diseases, having authored 3 papers that have together received 568 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (1 paper), Immune responses and vaccinations (1 paper) and COVID-19 Clinical Research Studies (1 paper). The work is most often cited by research in Immunology (311 citations), Neurology (51 citations) and Biological Psychiatry (13 citations). Ioanna D. Gemünd has collaborated with scholars based in Germany, Australia and Italy. Frequent co-authors include Lorenzo Bonaguro, Adem Saglam, Joachim L. Schultze, Emily Hinkley, Theodore S. Kapellos, Nico Reusch, Marc Beyer, Alexander Hoischen, Jonas Schulte-Schrepping and Peer Arts. Their work appears in journals such as Frontiers in Immunology and iScience.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026